Post job

Repros Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Mark L. Baum is the Repros Therapeutics's CEO. Repros Therapeutics has 30 employees, of which 12 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Repros Therapeutics executive team is 18% female and 82% male.
  • 70% of the management team is White.
  • 7% of Repros Therapeutics management is Hispanic or Latino.
  • 12% of the management team is Black or African American.
Work at Repros Therapeutics?
Share your experience

Rate Repros Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Mark L. Baum

Chairman & Chief Executive Officer

Joachim F. Wernicke

Chief Medical Officer

Joachim F. Wernicke is a Chief Medical Officer at REPROS THERAPEUTICS INC..

Katherine A. Anderson

Chief Financial Officer

Katherine A. Anderson is a Chief Financial Officer at REPROS THERAPEUTICS INC..

Andrew Livingston

Chief Innovation Officer

Andrew R. Boll

Chief Financial Officer & Secretary

John P. Saharek

President-Imprimisrx

Larry M. Dillaha

Chief Medical Officer

Marty Makary

Board Member

Perry J. Sternberg

Board Member

R. Lawrence van Horn

Board Member

Do you work at Repros Therapeutics?

Does leadership effectively guide Repros Therapeutics toward its goals?

Repros Therapeutics jobs

Repros Therapeutics board members

Name & TitleBio
Marty Makary

Board Member

Perry J. Sternberg

Board Member

R. Lawrence van Horn

Board Member

Richard L. Lindstrom

Board Member

Teresa F. Sparks

Board Member

Repros Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Repros Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Repros Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Repros Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Repros Therapeutics. The data presented on this page does not represent the view of Repros Therapeutics and its employees or that of Zippia.

Repros Therapeutics may also be known as or be related to REPROS THERAPEUTICS INC., Repros Therapeutics, Repros Therapeutics Inc and Repros Therapeutics Inc.